Different Cardiac Allograft Vasculopathy Progression is Observed Among Three Vessels After Heart Transplantation

被引：0
|
作者：
Ichibori, Yasuhiro
Kotani, Jun-Ichi
Tsukamoto, Yasumasa
Ohtani, Tomohito
Yamaguchi, Osamu
Tachibana, Koichi
Toda, Koichi
Fukushima, Norihide
Sawa, Yoshiki
Sakata, Yasushi
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Transplantation; Vulnerable plaque; Coronary artery disease; Atherosclerosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11590
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Effects of mTOR inhibitor-related proteinuria on progression of cardiac allograft vasculopathy and outcomes among heart transplant recipients
    Asleh, Rabea
    Alnsasra, Hilmi
    Lerman, Amir
    Briasoulis, Alexandros
    Pereira, Naveen L.
    Edwards, Brooks S.
    Toya, Takumi
    Stulak, John M.
    Clavell, Alfredo L.
    Daly, Richard C.
    Kushwaha, Sudhir S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (02) : 626 - 635
  • [32] Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation
    Ram, Eilon
    Lavee, Jacob
    Shechter, Michael
    Kogan, Alexander
    Maor, Elad
    Asher, Elad
    Freimark, Dov
    Klempfner, Robert
    Peled, Yael
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (10) : 1517 - 1523
  • [33] Prognostic Value of Biomarkers in Cardiac Allograft Vasculopathy following Heart Transplantation: A Literature Review
    Habibi, Shaghayegh
    Ghaffarpasand, Eiman
    Shojaei, Fahimehalsadat
    Alihashemi, Mahda
    Kahe, Farima
    Zahedi Tajrishi, Farbod
    Chi, Gerald
    CARDIOLOGY, 2020, 145 (11) : 693 - 702
  • [34] Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation
    Tremblay-Gravel, Maxime
    Racine, Normand
    de Denus, Simon
    Ducharme, Anique
    Pelletier, Guy B.
    Giraldeau, Genevieve
    Liszkowski, Mark
    Parent, Marie-Claude
    Carrier, Michel
    Fortier, Annik
    White, Michel
    JACC-HEART FAILURE, 2017, 5 (12) : 891 - 901
  • [35] Heart rate and cardiac allograft vasculopathy in heart transplant recipients
    Olmetti, Francesca
    Pinna, Gian Domenico
    Maestri, Roberto
    D'Armini, Andrea
    Pellegrini, Carlo
    Vigano, Mario
    Lilleri, Daniele
    Gerna, Giuseppe
    Febo, Oreste
    La Rovere, Maria Teresa
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12) : 1368 - 1373
  • [36] Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy With Improved Late Survival and Decreased Cardiac Events After Cardiac Transplantation
    Topilsky, Yan
    Hasin, Tal
    Raichlin, Eugenia
    Boilson, Barry A.
    Schirger, John A.
    Pereira, Naveen L.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Rodeheffer, Richard J.
    Frantz, Robert P.
    Maltais, Simon
    Park, Soon J.
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    CIRCULATION, 2012, 125 (05) : 708 - U153
  • [37] Virtual Histology Intravascular Ultrasound Assessment of Cardiac Allograft Vasculopathy From 1 to 20 Years After Heart Transplantation
    de la Torre Hernandez, Jose M.
    Vazquez de Prada, Jose A.
    Burgos, Virginia
    Sainz Laso, Fermin
    Fernandez Valls, Monica
    Gonzalez Vilchez, Francisco
    Llano, Miguel
    Ruano, Javier
    Zueco, Javier
    Colman, Thierry
    Martin Duran, Rafael
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02) : 156 - 162
  • [38] Statin therapy in cardiac allograft vasculopathy progression in heart transplant patients: Does potency matter?
    Sieg, Adam
    Weeks, Phillip
    Krustchinsky, Lori
    Rajapreyar, Indranee
    TRANSPLANTATION REVIEWS, 2016, 30 (03) : 178 - 186
  • [39] Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography
    Zanchin, Christian
    Yamaji, Kyohei
    Rogge, Carolin
    Lesche, Dorothea
    Zanchin, Thomas
    Ueki, Yasushi
    Windecker, Stephan
    Mohacsi, Paul
    Raber, Lorenz
    Sigurdardottir, Vilborg
    PLOS ONE, 2018, 13 (08):
  • [40] Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy
    El-Sayed, O
    Magorien, RD
    Orsini, A
    Ferketich, AK
    Leier, CV
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (02) : 137 - 141
12345